PADAGIS ANNOUNCES FDA APPROVAL AND LAUNCH OF A-RATED GENERIC VERSION OF UCERISĀ® (BUDESONIDE 2MG RECTAL FOAM)

ALLEGAN, Mich., April 28, 2023 /PRNewswire/ — Padagis today announced the launch of Budesonide 2mg Rectal Foam (generic to UcerisĀ®) with 180-days of Competitive Generic Therapy exclusivity. UcerisĀ® is a prescription corticosteroid medicine used to help get active, mild to moderate…